NFKB1 and juvenile idiopathic arthritis: This hypothesis is confirmed by the data of Nazarova et al. (2018), according to which the NFKB1 rs28362491*D allele reduces the risk of nonachieving the ACR Pedi 70 response to etanercept in JIA patients [33].